project id: TCGA-PAAD; case submitter id: TCGA-IB-A5SS; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.36; rna integrity number: 8.0; age at index: 64; days to birth: -23431; days to death: 460; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1947; year of death: 2012; age at diagnosis: 23431; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C25.0; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Tail of pancreas; synchronous malignancy: No; tissue or organ of origin: Tail of pancreas; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: No; cigarettes per day: 1.095890410958904; pack years smoked: 20.0; is ffpe: false; composition: Not Reported; days to collection: 491; days to sample procurement: 0; initial weight: 680.0; portion submitter id: TCGA-IB-A5SS-01A-11; percent lymphocyte infiltration: 12.0; percent monocyte infiltration: 1.0; percent necrosis: 15.0; percent neutrophil infiltration: 3.0; percent normal cells: 0.0; percent stromal cells: 55.0; percent tumor cells: 30.0; percent tumor nuclei: 60.0;